HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AMBI Scholarship in Science & Medicine

This article was originally published in The Rose Sheet

Executive Summary

Johnson & Johnson "ethnic" skin-care brand is accepting applications for its AMBI Scholarship in Science & Medicine, designed to "recognize, reward and support African-American and Hispanic women who have a genuine ambition to pursue careers in these respective fields" by awarding five women $10,000 each to help cover tuition costs, according to a Feb. 23 release. In particular, "non-traditional" students balancing a family, work and other professional goals who would like to return to school are invited to apply at 1www.AmbiFlawlessSkin.com through April 17. Company notes that in 2006 there were roughly 15,000 African American and 15,000 Hispanic female physicians versus more than 130,000 Caucasian female physicians. "AMBI Skincare has been used and trusted by women with richer skin tones for over 40 years to provide skincare solutions for flawless, even toned skin," the firm says. "With science being the key to the brand's success, AMBI extends its support to minority women who aspire to advance their careers in the sciences.

You may also be interested in...



Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 

Stockwatch: Choppy Waters For Teva And Bausch

After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.

 

 

Big Data Offers International Benefits

The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.

UsernamePublicRestriction

Register

RS015986

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel